Actively Recruiting
Intermittent Fasting in Prostate Cancer Patients Receiving Androgen Deprivation Therapy
Led by State University of New York at Buffalo · Updated on 2026-04-22
30
Participants Needed
1
Research Sites
264 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a a pilot study to assess the feasibility of intermittent caloric restriction (plus a plant-enriched diet optionally) in prostate cancer patients receiving androgen deprivation therapy. Study feasibility measures will include enrollment rate, drop-out rate and compliance with diet measured by self-reports.
CONDITIONS
Official Title
Intermittent Fasting in Prostate Cancer Patients Receiving Androgen Deprivation Therapy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Be male at birth and at least 18 years old on the day of signing informed consent
- Have measurable prostate cancer and be eligible for androgen deprivation therapy
- Have a performance status of 0-2 on the Eastern Cooperative Oncology Group (ECOG) scale
- Demonstrate adequate organ function with screening labs done within 10 days before treatment
- Have archival tumor tissue available or be willing to undergo a baseline biopsy before treatment
- Have a life expectancy of at least 6 months
- Be willing and able to provide written informed consent for the trial
You will not qualify if you...
- Have an ECOG performance status of 2 or higher
- Currently participating in another study or received investigational therapy/device within 4 weeks before treatment
- Have a known additional cancer that is progressing or requires active treatment
- Have any condition, therapy, or lab abnormality that might interfere with trial participation or results
- Have psychiatric or substance abuse disorders that would interfere with cooperation
- Have allergy, intolerance, or medical contraindication to contrast dye needed for CT/MRI imaging
- Have any other medical condition that could compromise adherence or study objectives
- Are not willing or able to provide written informed consent for the trial
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University at Buffalo/Great Lakes Cancer Center
Buffalo, New York, United States, 14203
Actively Recruiting
Research Team
R
Roberto Pili, MD
CONTACT
K
Kyle Pasquariello
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here